Physician Resource Hub: Advancing Care With Renasight™
This dedicated resource hub is designed to help you use Renasight™ to improve the diagnosis and management of patients with kidney disease. This page gives you access to the latest educational materials, how-to videos, FAQs, and digital tools to advance patient care.
Personalized care starts with Renasight™
In 2024, NKF, KDIGO, KDOQI, and a NEJM publication emphasized the critical role genetic testing plays in diagnosing and managing chronic kidney disease (CKD).1,2,3,4,6*. Below are resources to help you identify patients who can benefit from genetic testing.
Society endorsed patient indications for genetic testing1,2,5,6
Watch a webinar on the latest societal guidelines and recommendations for genetic testing
- Review the newest recommendations from NKF, KDIGO, and NEJM on genetic testing for CKD
- Learn how genetic testing impacts the diagnosis and management of kidney disease
See Renasight™ in action, review case examples
Discover how Renasight™ delivers meaningful utility and revolutionizes patient management through genetic insights. Explore real-world case examples demonstrating improved diagnostics, personalized treatment plans, and enhanced patient care
Explore Renasight™’s comprehensive kidney gene panel
*NKF and KDIGO do not endorse any specific test
References
1Stevens, P. E., et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4):S117–S314.
2Advancing genetic testing in kidney diseases: Report from a National Kidney Foundation working group. American Journal of Kidney Diseases. 2024;doi:10.1053/j.ajkd.2024.05.010.
3Navaneethan, S. D., et al. KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases. 2024.
4Genetics of Chronic Kidney Disease. New England Journal of Medicine. 2024;doi:10.1056/NEJMra2308577.
5Lentine, K. L., Kasiske, B. L., Levey, A. S., et al. KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation. 2017;101[8S Suppl 1]:S1–S109.
6Olivier et al. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Devuyst. Kidney International. Volume 107, Issue 2, S1 – S239.